J Clin Oncol
Rita Saude Conde, MD, Institut Jules Bordet, Brussels, Belgium; Giacomo Bregni, MD, Institut Jules Bordet, Brussels, Belgium, Université Libre de Bruxelles (ULB), Brussels, Belgium; Everardo Saad, MD, International Drug Development Institute, Louvain-la-Neuve, Belgium, Dendrix Research, Sao Paulo, Brazil; and Alain Hendlisz, MD, PhD, and Francesco Sclafani, MD, PhD, Institut Jules Bordet, Brussels, Belgium, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Published: March 2022